Open original FDA record ↗Recall record
- FDA identifier
- Z-2584-2024
- Company in FDA record
- Cepheid
- FDA classification date
- Aug 14, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Specimen collection device may leak after the patient sample swabs have been inserted into the test tubes, which could result in biohazard exposure, cross contamination causing false positive results for other specimens, and/or delay to test results.
Source facts
- Action
- On 6/20/24, "Urgent Medical Device Recall" notices dated 6/18/24 were sent to customers describing the product, problem and actions to taken. The notices informed them of the following: 1) Dispose of Collection/affected Devices from Copan lots you may currently have in use or in your inventory. 2) The quality issue with the Collection Device is intermittent, so the firm asks that if you receive a positive or negative test result, to please follow the Instructions for Use (IFU) for your specific assay, and your facility's protocol related to management of test results. 3) Share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter. 4) Complete and return the response via email to here: https://iqvia-response.my.site.com/mt/fca?cid=24far007 Firm is investigating the root cause of the reported leaking issue and working with the supplier to avoid recurrence in the future. For recall response support contact the firm at +1 844 920 1427 cepheidrecall-24far007@iqvia.com Outside the US phone +44 808 178 5381 Technical Support/Region/Country/Telephone/Email U.S./+1 888 838 3222, option 2/techsupport@cepheid.com; Latin America/N/A/latamsupport@cepheid.com; France/+ 33 563 825 319/support@cepheideurope.com; Germany/+ 49 21 514 474 524/support@cepheideurope.com; Portugal/+ 351 800 913 174/support@cepheideurope.com; Spain/+ 34 919 906 762/support@cepheideurope.com; Other European Countries/+ 33 563 825 319/support@cepheideurope.com; Hong Kong/N/A/techsupportapac@cepheid.com; Middle East and African Countries/+ 971 4 550 8617/support@cepheideurope.com; Other Countries Not Listed/+ 1 408 400 8495/techsupport@cepheid.com
- Initiated
- 2024-06-20
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution: US (nationwide): IL, TX, OH, LA, NY, CA, MD, IA, MN, KY, NH, WI, MO, NC, UT, WA, FL, NJ, SC, CO, PA, SD, NE, MT, WV, GA, MA, RI, CT, DE, MS, OK, VA, ID, AZ, OR, MI, IN, TN, AL, KS, ME, AR, NV, HI, AK, NM, WY, VT, ND, DC OUS (foreign) to countries of: Chile, Ireland, Oman, Nicaragua, Germany, San Marino, Ecuador, New Caledonia, France, Austria, United Kingdom, Finland, Italy, Hong Kong, Kuwait, United Arab Emirates, Netherlands, Belgium, Monaco, Colombia, Spain, Portugal, Poland, Switzerland, Denmark, Jersey, Mexico
- Recall number
- Z-2584-2024
- Recall status
- Open, Classified
- CDRH record ID
- 208841
- FDA classified
- 2024-08-14
- Recall event number
- 94932